876316-33-5,
4-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)morpholine,
2-(4-MORPHOLINOMETHYL)PHENYLBORONIC ACID PINACOL ESTER,
2-(Morpholinomethyl)phenylboronic acid pinacol ester,
2-(MORPHOLINOMETHYL)PHENYLBORONIC ACID, PINACOL ESTER,
4-{[2-(tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl}morpholine,
MFCD07781208,
4-[2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl]morpholine,
AMTB374,
SCHEMBL870038,
CTK8B3134,
DTXSID50585933,
WCNXVDLZTGODQW-UHFFFAOYSA-N,
BM428,
ANW-41826,
AKOS015960078,
ZINC169743717,
AB42572,
AM87355,
QC-4000,
RP06844,
RTR-027555,
TR-027555,
B-5267,
I06-2724,
J-513240,
2-(4-MORPHOLINYLMETHYL)BENZENEBORONIC ACID PINACOL ESTER,
2-(4-morpholinylmethyl)benzeneboronic acid pinacol ester, 95%,
2-(morpholin-4-ylmethyl)benzeneboronic acid, pinacol ester 95+%,
2-(Morpholinomethyl)phenylboronic acid pinacol ester, AldrichCPR,
2-[2-(Morpholinomethyl)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane,
4-(2-(4;4;5;5-tetraMethyl-1;3;2-dioxaborolan-2-yl)benzyl)Morpholine,
4-[2-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzyl]-morpholine,
4-{[2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl}morpholine,
C17H26BNO3,